Recent advances in molecular biology and immunohistochemistry have profoundly transformed the landscape of histopathological diagnostics in oncology. The identification of novel biomarkers has enhanced diagnostic accuracy, enabled early cancer detection, and improved therapeutic stratification. These markers, ranging from immunohistochemical antigens to genetic and epigenetic signatures, provide critical insights into tumor biology, proliferation, and metastatic potential. Modern histopathological diagnostics now integrate traditional morphology with molecular profiling to deliver precise, personalized cancer diagnosis. This article reviews emerging histopathological markers, their biological significance, and their applications in oncological practice.

The continuous development of molecular and cellular biology has profoundly transformed the landscape of oncological histopathology. In recent years, the discovery and implementation of new diagnostic and prognostic biomarkers have significantly enhanced the precision, reproducibility, and clinical relevance of cancer diagnostics. Histopathological diagnosis is no longer confined to morphological assessment alone but now integrates molecular signatures, immunohistochemical profiles, and genetic alterations that reflect the biological behavior of tumors. These markers serve as key tools in identifying tumor origin, predicting disease progression, and determining therapeutic response.

Immunohistochemical markers such as Ki-67, HER2/neu, PD-L1, and p53, as well as molecular markers including KRAS, EGFR, BRCA1/2, and BRAF, have become essential components of modern diagnostic protocols. Furthermore, the emergence of epigenetic markers, circulating microRNAs, and methylation patterns has provided novel non-invasive methods for early cancer detection and prognosis evaluation. By linking histological morphology with molecular pathogenesis, these biomarkers enable a multidimensional understanding of neoplastic processes and support the development of precision oncology.

Recent advances in digital pathology and artificial intelligence have also accelerated the discovery of novel histopathological markers, allowing automated quantification of tissue characteristics and pattern recognition at a microscopic level. This integration of computational analytics with traditional histology contributes to higher diagnostic accuracy, faster workflow, and the potential identification of previously unrecognized histological signatures.

Overall, the implementation of new markers in histopathological diagnostics marks a paradigm shift in oncology. These innovations not only improve the diagnostic and prognostic capabilities of pathologists but also promote personalized treatment strategies tailored to the molecular profile of each patient’s tumor. This review highlights the current trends, representative examples, and future perspectives of novel markers in oncological histopathology, emphasizing their critical role in the evolution of cancer diagnosis and therapy.

histopathology, biomarkers, oncology, immunohistochemistry, molecular diagnostics, cancer, prognosis

Allison, K. H., & Hammond, M. E. (2018). Molecular pathology in cancer diagnosis: Current practices and future directions. Modern Pathology, 31(1), 112–125.

Tsao, M. S., et al. (2021). Biomarker testing in lung cancer: Molecular diagnostics and therapeutic implications. Journal of Clinical Oncology, 39(13), 1443–1463.

Исраилова, Г. М., Эшмурадова, С. Т., & Тураев, И. Э. (2010). ГИГИЕНИЧЕСКАЯ ОЦЕНКА ФАКТОРОВ РИСКА ЗАГРЯЗНЕНИЯ МЯСОМОЛОЧНОЙ ПРОДУКЦИИ, ПРОИЗВОДИМОЙ В УСЛОВИЯХ МАЛОВОДЬЯ. Профилактическая и клиническая медицина, (1), 41-43.

Nurumbetova, S. (2022). VAIN ASPECTS OF PRACTICAL RELIGIOUS EXAMINATION IN THE INVESTIGATION OF CRIMES RELATED TO PROHIBITED RELIGIOUS MATERIALS. Science and Innovation, 1(6), 108-113.

Nurumbetova, S. (2023). MODERN OPPORTUNITIES AND PROSPECTS FOR DEVELOPMENT EXPERT-CRIMINALISTIC ACTIVITY. Modern Science and Research, 2(9), 415-419.

Nurumbetova, S. (2022). ДИНИЙ МАЗМУНДАГИ ТАҚИҚЛАНГАН МАТЕРИАЛЛАР БИЛАН БОҒЛИҚ ЖИНОЯТЛАРНИ ТЕРГОВ ҚИЛИШДА ДИНШУНОСЛИК ЭКСПЕРТИЗАСИНИ ЎТКАЗИШ АМАЛИЁТИНИНГ МУҲИМ ЖИҲАТЛАРИ. Science and innovation, 1(C6), 108-113.

Khalimovich, R. B. (2023). Simplification of criminal proceedings: concept, content and importance. World Bulletin of Management and Law, 18, 51-54.

Reis-Filho, J. S., & Lakhani, S. R. (2016). The contribution of molecular pathology to breast cancer classification and prognostication. Histopathology, 68(1), 57–70.

Louis, D. N., et al. (2021). The 2021 WHO classification of tumors of the central nervous system: A summary. Acta Neuropathologica, 142(4), 625–656.

Tan, P. H., Ellis, I., Allison, K., Brogi, E., et al. (2020). The World Health Organization classification of breast tumors. Histopathology, 77(2), 181–185.

Esteva, A., et al. (2019). A guide to deep learning in healthcare. Nature Medicine, 25(1), 24–29.